These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3918394)

  • 1. Influence of heparin and calcium chloride on assay, stability, and recovery of factor VIII.
    Morgenthaler JJ; Zuber T; Friedli H
    Vox Sang; 1985; 48(1):8-17. PubMed ID: 3918394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of heparin and calcium chloride on assay, stability, and recovery of factor VIII.
    Rock G
    Vox Sang; 1985; 49(5):370-2. PubMed ID: 3936278
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of factors affecting the stability of frozen heparinized plasma.
    Palmer DS; Rosborough D; Perkins H; Bolton T; Rock G; Ganz PR
    Vox Sang; 1993; 65(4):258-70. PubMed ID: 8310678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The stability of factor VIII in heparinized plasma.
    Krachmalnicoff A; Thomas DP
    Thromb Haemost; 1983 Jun; 49(3):224-7. PubMed ID: 6410534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved yields of factor VIII from heparinized plasma.
    Rock GA; Cruickshank WH; Tackaberry ES; Palmer DS
    Vox Sang; 1979; 36(5):294-300. PubMed ID: 462918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a heat-treated factor VIII/von Willebrand factor concentrate prepared from heparinized plasma.
    Palmer DS; Ganz PR; Perkins H; Rosborough D; Rock G
    Thromb Haemost; 1990 Jun; 63(3):392-402. PubMed ID: 2119525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severely heated therapeutic factor VIII concentrate of high specific activity.
    Winkelman L; Owen NE; Evans DR; Evans H; Haddon ME; Smith JK; Prince PJ; Williams JD; Lane RS
    Vox Sang; 1989; 57(2):97-103. PubMed ID: 2506696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the primary anticoagulant on the recovery of factor VIII in cryoprecipitate.
    de Wit HJ; Scheer G; Muradin J; van der Does JA
    Vox Sang; 1986; 51(3):172-5. PubMed ID: 3101286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of improved cryoprecipitated factor VIII concentrate. A controlled study of three variables affecting the yield.
    Wensley RT; Snape TJ
    Vox Sang; 1980; 38(4):222-8. PubMed ID: 6774480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of cryoprecipitate of intermediate purity in a closed system thaw-siphon process.
    Mason EC; Pepper DS; Griffin B
    Thromb Haemost; 1981 Aug; 46(2):543-6. PubMed ID: 6795742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple plasma anticoagulant-exchange method to increase the recovery of factor VIII in therapeutic concentrates.
    Cumming AM; Wensley RT; Winkelman L; Lane RS
    Vox Sang; 1990; 58(4):264-9. PubMed ID: 2119086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The assay of factor VIII: C in heparinized plasma: a polybrene neutralization method.
    Cumming AM; Wensley RT; Delamore IW
    Thromb Haemost; 1986 Feb; 55(1):58-60. PubMed ID: 3085265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thaw-siphon technique for production of cryoprecipitate concentrate of factor VIII.
    Mason EC
    Lancet; 1978 Jul; 2(8079):15-7. PubMed ID: 78212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in factor VIII complex activities during the production of a clinical intermediate purity factor VIII concentrate.
    Prowse CV; Griffin B; Pepper DS; Dickson AJ; McQuillan TA; Dickson IH; Foster PR
    Thromb Haemost; 1981 Oct; 46(3):597-601. PubMed ID: 6797090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of large-scale plasma thawing for recovery of cryoprecipitate factor VIII.
    Foster PR; Dickson AJ; McQuillan TA; Dickson IH; Keddie S; Watt JG
    Vox Sang; 1982; 42(4):180-9. PubMed ID: 6806984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased yield of F VIII from pooled plasma vs. single-donor plasma in the production of cryoprecipitates.
    Rácz Z; Thék M; Jánossy A; Pintér J; Baróti C
    Arch Med Res; 1997; 28(2):179-82. PubMed ID: 9204605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of VIII:C in plasma: the dependence on protease activity and calcium.
    Rock GA; Cruickshank WH; Tackaberry ES; Ganz PR; Palmer DS
    Thromb Res; 1983 Mar; 29(5):521-35. PubMed ID: 6407138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of calcium ions on the activated partial thromboplastin time of heparinized plasma.
    Greenberg CS; Adams JP; Mullen PE; Koepke JA
    Am J Clin Pathol; 1986 Oct; 86(4):484-9. PubMed ID: 3766461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of heparin on the interaction of factor VIII and human platelets in vitro.
    de Marco L; Fabris F; Molaro G; Girolami A
    Haemostasis; 1977; 6(3):163-70. PubMed ID: 885379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double cryoprecipitated factor VIII concentrate from heparinised plasma and its heat treatment.
    Smit Sibinga CT; Schulting PJ; Notebomer J; Das PC; Marrink J; vd Meer J
    Blut; 1988 Mar; 56(3):111-6. PubMed ID: 3128351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.